Powered by the innovation that made us a leader in Life Sciences
Dates coming soon
Illumina sequencing is fueling groundbreaking discoveries across a wide range of research areas. By enabling the broadest range of applications including whole-genome resequencing, de novo sequencing, targeted resequencing, transcriptome and epigenetic analysis, researchers are publishing at amazing rates.
This seminar series will showcase presentations from scientists using Illumina technology to power their next-generation sequencing studies. We invite you to join us, learn about their research, and receive an update on new sequencing products from Illumina.
The complementary technologies of next-generation sequencing and microarray-based genotyping are enabling discovery in the field of genetic research at an unprecedented rate. Massive resequencing efforts, such as The 1000 Genomes Project, are delivering an expanded catalogue of previously unknown genetic variation. This novel content can be utilized for the creation of next-generation microarrays allowing the exploration of new hypotheses in the role of genetic variation in heath and disease.
This seminar series will discuss the science behind array-based genome-wide association studies (GWAS), recent discoveries, and new tools leveraging Illumina technology to power the next wave of discovery. Learn how the Omni family of microarrays can empower you to reach your ultimate research goals. With up to 50% more coverage of common and rare variants. Maximum power for any population. Multiple product paths and flexible points of entry. Always the latest content. It's next-gen GWAS with the whole genome in mind.
Global issues. Genetic answers. Rapid population expansion on a finite amount of land. It's at the core of our planet's challenges. Getting the most out of agriculture. Minimizing environmental impact. Use Illumina's advanced genetic analysis tools to meet these challenges. Discover more. Validate selections. Screen for the traits that will make a difference.
At this seminar series, you'll hear compelling presentations from scientists using Illumina technology to expand their research and perform the studies they only dreamed of a few years ago. With the industry's most comprehensive genetic analysis tool set, we're here to provide the power you need. Power to find the most desirable traits. It's time for a new evolution in genetic research.
Powered by the innovation that made us a leader in Life Sciences, IlluminaDx is dedicated to developing the next generation of molecular tests, systems and services that enable earlier diagnosis, selection of appropriate therapies and monitoring of disease progression. Our vision is to become a leader in translational medicine, focusing on complex diseases that benefit from high performance analysis, including genotyping, copy number, gene expression, methylation and protein analysis.
In this seminar series, you will have the opportunity to learn how IlluminaDx is leveraging the strength of our technologies in four major areas: